Back to Agenda
Session 9: FDA's Actions on the Original IND & Future Amendments
Session Chair(s)
Michael Hamrell, PhD, RAC
President
MORIAH Consultants, United States
- FDA’s Review of an IND
- Clinical Holds: Basis for Imposition and Process for Removal
Have an account?